Gary Buehler, the director of the FDA’s Office of Generic Drugs, has changed positions at the agency and will now serve in the Office of Pharmaceutical Science, which oversees the generics area. Mr. Buehler led the generics office for 10 years. Keith Webber, the deputy director of the Office of Pharmaceutical Science, will take over for Mr. Buehler on an interim basis. According to information presented by the FDA at the Generic Pharmaceutical Association convention last month, Mr. Buehler&#8...